ENGNW icon

enGene Therapeutics Warrants
ENGNW

11 hedge funds and large institutions have $12.9M invested in enGene Therapeutics Warrants in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

21% less funds holding

Funds holding: 14 → 11 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$175K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.41M
2
+$715K
3
+$487K
4
ICM
Ionic Capital Management
New York
+$49.6K

Top Sellers

1
-$844K
2
-$420K
3
-$418K
4
SCM
Saba Capital Management
New York
-$288K
5
WAM
Wolverine Asset Management
Illinois
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
FIS
1
FCPM III Services
Netherlands
$7.28M
BI
2
BVF Inc
California
$2.49M
BOCH
3
Blue Owl Capital Holdings
New York
$1.29M
LP
4
LMR Partners
United Kingdom
$811K
AC
5
Aristeia Capital
Connecticut
$445K
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$275K
TCM
7
Tenor Capital Management
New York
$140K
SCM
8
Saba Capital Management
New York
$101K
CL
9
CSS LLC
Illinois
$42.7K
ICM
10
Ionic Capital Management
New York
$42.4K
CS
11
Clear Street
New York
$759
VC
12
Vivo Capital
California
–
Calamos Advisors
13
Calamos Advisors
Illinois
–
CM
14
Caption Management
Oklahoma
–
WAM
15
Wolverine Asset Management
Illinois
–
Bank of America
16
Bank of America
North Carolina
–